Search research articles
Contact Us
Filters
Showing results (151-160 of 272) with videos related to
Page
of 28
Sort By:
ACR Open Rheumatology
|
September 22, 2021
The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases
Jeffrey R Curtis, Kevin Winthrop, Rhonda L Bohn, et al.
Rheumatology and Therapy
|
January 20, 2026
Patients' Perspectives Regarding Ankylosing Spondylitis Treatment Administration Features: Evidence from Qualitative Interviews and a Multinational Quantitative Preference Survey
Atul Deodhar, Martine C Maculaitis, Lewis Kopenhafer, et al.
Annals of the Rheumatic Diseases
|
May 7, 2013
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Jürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Arthritis Care & Research
|
November 23, 2020
Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled Trials
Tore K Kvien, Philip G Conaghan, Laure Gossec, et al.
The Journal of Rheumatology
|
March 3, 2019
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D Reveille, Atul Deodhar, Paul H Caldron, et al.
Arthritis and Rheumatism
|
September 2, 2008
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period
Jürgen Braun, Atul Deodhar, Ben Dijkmans, et al.
The Journal of Rheumatology
|
April 1, 2026
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D Reveille, Atul Deodhar, Paul H Caldron, et al.
The New England Journal of Medicine
|
December 25, 2015
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten, Joachim Sieper, Jürgen Braun, et al.
Clinical Rheumatology
|
August 16, 2020
Assessing rheumatologists' attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort
Neha Rich-Garg, Abhijeet Danve, Dongseok Choi, et al.
Rheumatology and Therapy
|
September 30, 2022
Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review
Irene E van der Horst-Bruinsma, Philip C Robinson, Ennio G Favalli, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 272) with videos related to
Sort By:
Page
of 28
ACR Open Rheumatology
|
September 22, 2021
The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases
Jeffrey R Curtis, Kevin Winthrop, Rhonda L Bohn, et al.
Rheumatology and Therapy
|
January 20, 2026
Patients' Perspectives Regarding Ankylosing Spondylitis Treatment Administration Features: Evidence from Qualitative Interviews and a Multinational Quantitative Preference Survey
Atul Deodhar, Martine C Maculaitis, Lewis Kopenhafer, et al.
Annals of the Rheumatic Diseases
|
May 7, 2013
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Jürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Arthritis Care & Research
|
November 23, 2020
Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled Trials
Tore K Kvien, Philip G Conaghan, Laure Gossec, et al.
The Journal of Rheumatology
|
March 3, 2019
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D Reveille, Atul Deodhar, Paul H Caldron, et al.
Arthritis and Rheumatism
|
September 2, 2008
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period
Jürgen Braun, Atul Deodhar, Ben Dijkmans, et al.
The Journal of Rheumatology
|
April 1, 2026
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D Reveille, Atul Deodhar, Paul H Caldron, et al.
The New England Journal of Medicine
|
December 25, 2015
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten, Joachim Sieper, Jürgen Braun, et al.
Clinical Rheumatology
|
August 16, 2020
Assessing rheumatologists' attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort
Neha Rich-Garg, Abhijeet Danve, Dongseok Choi, et al.
Rheumatology and Therapy
|
September 30, 2022
Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review
Irene E van der Horst-Bruinsma, Philip C Robinson, Ennio G Favalli, et al.
Page
of 28